BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

374 related articles for article (PubMed ID: 26829751)

  • 21. The chicken Pdcd4 gene is regulated by v-Myb.
    Schlichter U; Burk O; Worpenberg S; Klempnauer KH
    Oncogene; 2001 Jan; 20(2):231-9. PubMed ID: 11313950
    [TBL] [Abstract][Full Text] [Related]  

  • 22. QKI-7 regulates expression of interferon-related genes in human astrocyte glioma cells.
    Jiang L; Saetre P; Radomska KJ; Jazin E; Lindholm Carlström E
    PLoS One; 2010 Sep; 5(9):. PubMed ID: 20927331
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MYB-NFIB gene fusion in adenoid cystic carcinoma of the breast with special focus paid to the solid variant with basaloid features.
    D'Alfonso TM; Mosquera JM; MacDonald TY; Padilla J; Liu YF; Rubin MA; Shin SJ
    Hum Pathol; 2014 Nov; 45(11):2270-80. PubMed ID: 25217885
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification of a Myb-responsive enhancer of the chicken C/EBPbeta gene.
    Kintscher J; Yamkamon V; Braas D; Klempnauer KH
    Oncogene; 2004 Jul; 23(34):5807-14. PubMed ID: 15195136
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A dual activation mechanism for Myb-responsive genes in myelomonocytic cells.
    Yamkamon V; Ivanova O; Braas D; Chayka O; Patmasiriwat P; Klempnauer KH
    Blood Cells Mol Dis; 2008; 40(2):219-26. PubMed ID: 17950008
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Detection of Enhancer-Associated Rearrangements Reveals Mechanisms of Oncogene Dysregulation in B-cell Lymphoma.
    Ryan RJ; Drier Y; Whitton H; Cotton MJ; Kaur J; Issner R; Gillespie S; Epstein CB; Nardi V; Sohani AR; Hochberg EP; Bernstein BE
    Cancer Discov; 2015 Oct; 5(10):1058-71. PubMed ID: 26229090
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Genomic dynamics associated with malignant transformation in IDH1 mutated gliomas.
    Park CK; Park I; Lee S; Sun CH; Koh Y; Park SH; Kim JE; Yun H; Lee SH
    Oncotarget; 2015 Dec; 6(41):43653-66. PubMed ID: 26524630
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Glioma stem cells are more aggressive in recurrent tumors with malignant progression than in the primary tumor, and both can be maintained long-term in vitro.
    Huang Q; Zhang QB; Dong J; Wu YY; Shen YT; Zhao YD; Zhu YD; Diao Y; Wang AD; Lan Q
    BMC Cancer; 2008 Oct; 8():304. PubMed ID: 18940013
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expression profiles of 151 pediatric low-grade gliomas reveal molecular differences associated with location and histological subtype.
    Bergthold G; Bandopadhayay P; Hoshida Y; Ramkissoon S; Ramkissoon L; Rich B; Maire CL; Paolella BR; Schumacher SE; Tabak B; Ferrer-Luna R; Ozek M; Sav A; Santagata S; Wen PY; Goumnerova LC; Ligon AH; Stiles C; Segal R; Golub T; Grill J; Ligon KL; Chan JA; Kieran MW; Beroukhim R
    Neuro Oncol; 2015 Nov; 17(11):1486-96. PubMed ID: 25825052
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The MYB proto-oncogene suppresses monocytic differentiation of acute myeloid leukemia cells via transcriptional activation of its target gene GFI1.
    Zhao L; Ye P; Gonda TJ
    Oncogene; 2014 Aug; 33(35):4442-9. PubMed ID: 24121275
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The landscape and therapeutic relevance of cancer-associated transcript fusions.
    Yoshihara K; Wang Q; Torres-Garcia W; Zheng S; Vegesna R; Kim H; Verhaak RG
    Oncogene; 2015 Sep; 34(37):4845-54. PubMed ID: 25500544
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of novel genomic markers related to progression to glioblastoma through genomic profiling of 25 primary glioma cell lines.
    Roversi G; Pfundt R; Moroni RF; Magnani I; van Reijmersdal S; Pollo B; Straatman H; Larizza L; Schoenmakers EF
    Oncogene; 2006 Mar; 25(10):1571-83. PubMed ID: 16247447
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Angiocentric glioma: report of clinico-pathologic and genetic findings in 8 cases.
    Preusser M; Hoischen A; Novak K; Czech T; Prayer D; Hainfellner JA; Baumgartner C; Woermann FG; Tuxhorn IE; Pannek HW; Bergmann M; Radlwimmer B; Villagrán R; Weber RG; Hans VH
    Am J Surg Pathol; 2007 Nov; 31(11):1709-18. PubMed ID: 18059228
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Downregulation of tumor suppressor QKI in gastric cancer and its implication in cancer prognosis.
    Bian Y; Wang L; Lu H; Yang G; Zhang Z; Fu H; Lu X; Wei M; Sun J; Zhao Q; Dong G; Lu Z
    Biochem Biophys Res Commun; 2012 May; 422(1):187-93. PubMed ID: 22569043
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Oncogenic FAM131B-BRAF fusion resulting from 7q34 deletion comprises an alternative mechanism of MAPK pathway activation in pilocytic astrocytoma.
    Cin H; Meyer C; Herr R; Janzarik WG; Lambert S; Jones DT; Jacob K; Benner A; Witt H; Remke M; Bender S; Falkenstein F; Van Anh TN; Olbrich H; von Deimling A; Pekrun A; Kulozik AE; Gnekow A; Scheurlen W; Witt O; Omran H; Jabado N; Collins VP; Brummer T; Marschalek R; Lichter P; Korshunov A; Pfister SM
    Acta Neuropathol; 2011 Jun; 121(6):763-74. PubMed ID: 21424530
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Analysis of balanced rearrangements of chromosome 6 in acute leukemia: clustered breakpoints in q22-q23 and possible involvement of c-MYB in a new recurrent translocation, t(6;7)(q23;q32 through 36).
    Sinclair P; Harrison CJ; Jarosová M; Foroni L
    Haematologica; 2005 May; 90(5):602-11. PubMed ID: 15921375
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Histone H3 tail positioning and acetylation by the c-Myb but not the v-Myb DNA-binding SANT domain.
    Mo X; Kowenz-Leutz E; Laumonnier Y; Xu H; Leutz A
    Genes Dev; 2005 Oct; 19(20):2447-57. PubMed ID: 16195416
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Translocation-associated salivary gland tumors: a review and update.
    Weinreb I
    Adv Anat Pathol; 2013 Nov; 20(6):367-77. PubMed ID: 24113307
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical management and genomic profiling of pediatric low-grade gliomas in Saudi Arabia.
    Mobark NA; Alharbi M; Alhabeeb L; AlMubarak L; Alaljelaify R; AlSaeed M; Almutairi A; Alqubaishi F; Ahmad M; Al-Banyan A; Alotabi FE; Barakeh D; AlZahrani M; Al-Khalidi H; Ajlan A; Ramkissoon LA; Ramkissoon SH; Abedalthagafi M
    PLoS One; 2020; 15(1):e0228356. PubMed ID: 31995621
    [TBL] [Abstract][Full Text] [Related]  

  • 40. BRAF mutation and CDKN2A deletion define a clinically distinct subgroup of childhood secondary high-grade glioma.
    Mistry M; Zhukova N; Merico D; Rakopoulos P; Krishnatry R; Shago M; Stavropoulos J; Alon N; Pole JD; Ray PN; Navickiene V; Mangerel J; Remke M; Buczkowicz P; Ramaswamy V; Guerreiro Stucklin A; Li M; Young EJ; Zhang C; Castelo-Branco P; Bakry D; Laughlin S; Shlien A; Chan J; Ligon KL; Rutka JT; Dirks PB; Taylor MD; Greenberg M; Malkin D; Huang A; Bouffet E; Hawkins CE; Tabori U
    J Clin Oncol; 2015 Mar; 33(9):1015-22. PubMed ID: 25667294
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.